Skip to main content
Equibles

2796 · Pharmarise Holdings Corporation · Financials

Use 2796 with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research 2796.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
507 JPY +0 (+0.00%) At close · Nov 13
Rebalance outlook locked
Market Cap
5.83B JPY
Shares
11.50M
Volume · Nov 13 4700 Avg daily vol (3M) 6357

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Pull these statements through the financial statements API or MCP →
Revenue
69.51B +9.5%
FY2026 Revenue FY2022–FY2026
Net Income
114M +131.1%
FY2026 Net Income FY2022–FY2026
Gross Margin
13.61% -0.5pp
FY2026 Gross Margin FY2022–FY2026
Operating Margin
1.41% +1pp
FY2026 Operating Margin FY2022–FY2026
Operating Cash Flow
3.28B +150%
FY2026 Operating Cash Flow FY2022–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item FY2026 FY2025 FY2024 FY2023 FY2022
JPY 69.51B 63.51B 54.47B 52.03B 51.61B
JPY 60.05B 54.54B 46.02B 43.9B 43.49B
JPY 9.46B 8.97B 8.45B 8.13B 8.12B
JPY 979M 293M 916M 1.44B 1.52B
JPY 698M 8M 143M 1.05B 1.32B
JPY 591M 390M 485M 702M 864M
JPY 114M -367M -351M 333M 447M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 771M in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.